The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1521
ISSUE 1521
May 22, 2017
Issue 1521
- Prescription Drug Prices in the US
- Valbenazine (Ingrezza) for Tardive Dyskinesia
- Oxymetazoline Cream (Rhofade) for Rosacea
- FDA Warns Against Use of Codeine and Tramadol in Children and Breastfeeding Women
- Another Subcutaneous Immune Globulin (Cuvitru) for Primary Immunodeficiency (online only)
- Vonvendi - Recombinant von Willebrand Factor (online only)
- Comparison Table: Some Topical Drugs for Rosacea (online only)
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Prescription Drug Prices in the US
May 22, 2017 (Issue: 1521)
Per capita spending on prescription drugs in the US is
higher than in other industrialized nations, including
Canada.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.